Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20091
20102
20112
20121
20131
20144
20152
20173
20191
20201
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Novartis Pharmaceuticals3
Pfizer3
Assistance Publique - Hôpitaux de Paris2
Gilead Sciences2
Pharmacyclics LLC.2
AbbVie1
AstraZeneca1
Centre Hospitalier Intercommunal Creteil1
Faes Farma, S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome25
Hepatitis C3
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Follicular3
Arthralgia2
Arthritis, Juvenile2
Graft vs Host Disease2
Psoriasis2
Anemia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.